DocGo (DCGO) Reiterated at Buy by Stifel After Q2 Miss
Stifel analyst David Grossman reiterated a Buy rating and $2.50 price target on DocGo (NASDAQ: DCGO).The analyst commented, "2Q revenue/EBITDA ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
